Highly potent active pharmaceutical ingredients (HPAPIs) are becoming more common in solid dose manufacturing. How can isolation and containment equipment help manufacturers ensure safe and pure environments for working with these toxic compounds?
This is the question Gerard Geiger, Nilfisk business development manager for the pharmaceutical industry, takes on in this month’s Tablets & Capsules: Solid Dose Digest.
Read his response here.
